60 Degrees Pharmaceuticals IncSXTP
Price$1.33

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value not published yet, our data-reliability standards weren't met; method estimates belowbased on filings through 30 Jun 2026
Market Price $1.33Price as of 30 Sep 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Discount rate (cost of equity) 14.1%
Volatility vs market (adjusted beta)2.02

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
Target60 Degrees Pharmaceuticals IncSXTPHealth Care
Valuation
P/E—
P/S3.0×
P/B0.9×
EV / Revenue2.2×
EV / EBITDA-0.2×
Profitability
Gross margin22.3%
Operating margin-772.1%
Net margin-729.9%
FCF margin-800.6%
Returns
ROE-310.2%
ROA-189.3%
ROIC—
Growth
Revenue growth (YoY)82.9%
5-yr fwd EPS growth—
Financial strength
Debt / Equity0.06×
Current ratio2.32×
Altman Z-Score-21.6
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.